section name header

Basics

Outline


BASICS

Definition!!navigator!!

  • Myopathy causing chronic exertional rhabdomyolysis characterized by increased skeletal muscle glycogen and amylase-resistant polysaccharide inclusions.
  • Type 1 PSSM and type 2 PSSM recognized

Pathophysiology!!navigator!!

  • PSSM1 has a genetic basis.
  • Unknown PSSM2 cause(s)

Systems Affected!!navigator!!

  • Endocrine/metabolic.
  • Neuromuscular.
  • Renal

Genetics!!navigator!!

  • PSSM1—autosomal dominant mutation in GYS1 gene.
  • PSSM2—possibly heredity in Quarter Horses

Incidence/Prevalence!!navigator!!

PSSM1 breed prevalence—North American Belgian, Percheron (high); Shire, Clydesdale (low); Quarter Horses (6–10%); Paint, Appaloosa (6–8%); halter Quarter Horses (28%); racing Quarter Horses (low); Warmblood, Irish Draught, Cob, Connemara (low); Arabian, Standardbred, Thoroughbred (very low).

Geographic Distribution!!navigator!!

  • Worldwide

Signalment!!navigator!!

  • 2–4-year-old Quarter Horses.
  • ±Foal

Signs!!navigator!!

Quarter Horses

  • “Tying-up” episodes shortly after exercise characterized by muscle stiffness, sweating, reluctance to move.
  • Tachypnea, tachycardia, muscle fasciculations, tucked-up abdomen, camped-out stance, firm painful lumbar and gluteal muscles, gait asymmetry, hindlimb stiffness.
  • Subclinical to severe with recumbency and renal failure.
  • Pawing or rolling, ± resembles colic.
  • ±Rapid muscle atrophy after concurrent respiratory disease

Draft Horses

  • Variable—normal to weakness, recumbency.
  • Muscle soreness.
  • Generalized muscle atrophy.
  • Exertional rhabdomyolysis.
  • Hindlimb weakness, difficulty rising

Causes!!navigator!!

Hereditary ± environmental influence.

Diagnosis

Outline


DIAGNOSIS

Differential Diagnosis!!navigator!!

  • Sporadic or chronic exertional rhabdomyolysis.
  • Non-exercise-associated rhabdomyolysis, e.g. infectious and immune-mediated myopathies (Clostridium, influenza, Streptococcus equi ssp. equi, Sarcocystis), nutritional myodegeneration, traumatic myopathy, idiopathic pasture myopathy, and toxic muscle damage, e.g. monensin, white snake root ingestion.
  • Colic.
  • Laminitis.
  • Pleuropneumonia.
  • Aortoiliac thrombosis.
  • Tetanus.
  • Hyperkalemic periodic paralysis.
  • Recumbent neuropathy

CBC/Biochemistry/Urinalysis!!navigator!!

  • CK, AST elevations (>10 000 U/L) after exercise.
  • Persistent CK elevation.
  • Myoglobinuria.
  • ±Azotemia.
  • ±High potassium and low sodium and chloride serum concentrations.
  • ±CK, AST elevation in draft horses

Other Laboratory Tests!!navigator!!

  • Serum vitamin E and whole-blood selenium to rule out deficiency.
  • Fractional excretion of urine electrolytes.
  • Genetic testing for GYS1 mutation

Other Diagnostic Procedures!!navigator!!

  • Muscle (semimembranosus/tendinosus) biopsy.
  • Submaximal exercise test—>3–4-fold increased CK 4–6 h after 15 min walk/trot

Pathologic Findings!!navigator!!

Skeletal muscle—subsarcolemmal vacuoles, increased glycogen staining, amylase-resistant polysaccharide accumulation.

Treatment

Outline


TREATMENT

Appropriate Health Care!!navigator!!

  • Acute episode—oral and/or IV balanced polyionic fluids ± electrolytes, analgesia, rest.
  • Appropriate diet and exercise

Activity!!navigator!!

Daily turnout, gradual return to consistent exercise.

Diet!!navigator!!

  • Forage 1.5–2% of body weight.
  • Low-starch (<10% daily energy) diet.
  • Eliminate grain, replace with fat (corn or soy oil).
  • ±Commercial made low-starch, high-fat ration

Client Education!!navigator!!

Appropriate diet and exercise management to control clinical signs.

Medications

Outline


MEDICATIONS

Drug(s) of Choice!!navigator!!

  • NSAIDs—phenylbutazone (4.4 mg/kg IV or PO every 12 h for 1 day then 2.2 mg/kg PO every 12 h) or flunixin meglumine (0.5–1.1 mg/kg IV or PO every 12–24 h). Care if dehydrated or myoglobinuric
  • Acepromazine (0.04–0.11 mg/kg IV or IM every 8–12 h).
  • ±Detomidine (0.005–0.02 mg/kg IV or IM).
  • ±Methocarbamol (40–60 mg/kg PO daily).
  • ±IV DMSO (<10% solution)

Contraindications!!navigator!!

  • NSAIDs with dehydration or myoglobinuria.
  • Acepromazine with dehydration

Follow-up

Outline


FOLLOW-UP

Patient Monitoring!!navigator!!

  • Monitor signs, especially during abrupt training changes.
  • Serum CK (resting or 4 h post exercise) prior to restarting exercise.
  • If myoglobinuria, monitor renal parameters.
  • If depressed or inappetent after acute episode, suspect acute renal failure and treat promptly

Prevention/Avoidance!!navigator!!

  • Low-starch, high-fat diet.
  • Daily exercise and turnout careful obesity does not occur

Possible Complications!!navigator!!

  • Severe rhabdomyolysis and muscle damage, recumbency, death.
  • Renal failure

Expected Course and Prognosis!!navigator!!

With proper diet and exercise, good prognosis for athletics.

Miscellaneous

Outline


MISCELLANEOUS

Associated Conditions!!navigator!!

Severe rapid muscle atrophy after concurrent respiratory disease in Quarter Horses.

Age-Related Factors!!navigator!!

  • ±Signs and rhabdomyolysis in 1-day-old foal.
  • Muscle biopsy abnormalities after 1 year of age

Pregnancy/Fertility/Breeding!!navigator!!

Heritable disorder, counsel breeders.

Synonyms!!navigator!!

  • EPSM, EPSSM (equine polysaccharide storage myopathy).
  • Azoturia.
  • Monday morning disease

Abbreviations!!navigator!!

  • AST = aspartate aminotransferase.
  • CK = creatine phosphokinase.
  • DMSO = dimethylsulfoxide.
  • GYS1 = glycogen synthase 1.
  • NSAID = nonsteroidal anti-inflammatory drug.
  • PSSM = polysaccharide storage myopathy

Suggested Reading

Valberg SJ. Diseases of muscle. In: Smith BP, ed. Large Animal Internal Medicine, 5e. St. Louis, MO: Elsevier Mosby, 2015:12991304.

Author(s)

Author: Anna M. Firshman

Consulting Editor: Elizabeth J. Davidson